| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Compass Therapeutics (NASDAQ:CMPX) through any online brokerage.
Other companies in Compass Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Compass Therapeutics has a consensus price target of $8.57.
The stock price for Compass Therapeutics (NASDAQ: CMPX) is $0.80915 last updated October 21, 2026 at 10:06 AM EDT.
There are no upcoming dividends for Compass Therapeutics.
Compass Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Compass Therapeutics.
Compass Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
